cytarabine has been researched along with prostratin in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Cong, YW; Cui, Y; Dong, B; Jing, Y; Liu, XL; Luo, QL; Shan, YJ; Shen, X; Wang, LS; Xiao, H; Xing, S; Xiong, GL; Yang, M; Yu, ZY; Zhang, YF | 1 |
1 other study(ies) available for cytarabine and prostratin
Article | Year |
---|---|
The protein kinase C agonist prostratin induces differentiation of human myeloid leukemia cells and enhances cellular differentiation by chemotherapeutic agents.
Topics: Antineoplastic Agents; Apoptosis; Blotting, Western; Cell Cycle; Cell Differentiation; Cell Proliferation; Cytarabine; Drug Synergism; Extracellular Signal-Regulated MAP Kinases; Humans; Leukemia, Myeloid, Acute; Phorbol Esters; Protein Kinase C; Proto-Oncogene Proteins c-myc; Tumor Cells, Cultured | 2015 |